REPORT ID 520

EMEA (Europe, Middle East and Africa) Non-opioid Pain Patches Market Report 2017

Publish Date
04-Dec-17
Pages
117
Format
Electronic (PDF)

In this report, the EMEA Non-opioid Pain Patches market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Non-opioid Pain Patches for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Non-opioid Pain Patches market competition by top manufacturers/players, with Non-opioid Pain Patches sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    GlaxoSmithKline
    Johnson & Johnson
    Novartis AG
    Mylan N.V.
    Teva Pharmaceutical Industries
    Hisamitsu Pharmaceutical
    TEH SENG Pharmaceutical
    Teikoku Seiyaku
    IBSA Institut Biochimque SA
    Acorda Therapeutics
    Allergan PLC
    Endo International

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Lidocaine Patch
    Diclofenac Patch
    Methyl Salicylate Patch
    Capsaicin Patch
    Ketoprofen Patch
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacies
    Independent Pharmacies & Drug Stores
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Non-opioid Pain Patches Market Report 2017
1 Non-opioid Pain Patches Overview
    1.1 Product Overview and Scope of Non-opioid Pain Patches
    1.2 Classification of Non-opioid Pain Patches
        1.2.1 EMEA Non-opioid Pain Patches Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Non-opioid Pain Patches Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Lidocaine Patch
        1.2.4 Diclofenac Patch
        1.2.5 Methyl Salicylate Patch
        1.2.6 Capsaicin Patch
        1.2.7 Ketoprofen Patch
        1.2.8 Other
    1.3 EMEA Non-opioid Pain Patches Market by Application/End Users
        1.3.1 EMEA Non-opioid Pain Patches Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Hospital Pharmacies
        1.3.3 Independent Pharmacies & Drug Stores
        1.3.4 Online Pharmacies
    1.4 EMEA Non-opioid Pain Patches Market by Region
        1.4.1 EMEA Non-opioid Pain Patches Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Non-opioid Pain Patches (2012-2022)
        1.5.1 EMEA Non-opioid Pain Patches Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Non-opioid Pain Patches Revenue and Growth Rate (2012-2022)

2 EMEA Non-opioid Pain Patches Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Non-opioid Pain Patches Market Competition by Players/Manufacturers
        2.1.1 EMEA Non-opioid Pain Patches Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Non-opioid Pain Patches Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Non-opioid Pain Patches Sale Price by Players (2012-2017)
    2.2 EMEA Non-opioid Pain Patches (Volume and Value) by Type/Product Category
        2.2.1 EMEA Non-opioid Pain Patches Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Non-opioid Pain Patches Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Non-opioid Pain Patches Sale Price by Type (2012-2017)
    2.3 EMEA Non-opioid Pain Patches (Volume) by Application
    2.4 EMEA Non-opioid Pain Patches (Volume and Value) by Region
        2.4.1 EMEA Non-opioid Pain Patches Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Non-opioid Pain Patches Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Non-opioid Pain Patches Sales Price by Region (2012-2017)

3 Europe Non-opioid Pain Patches (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Non-opioid Pain Patches Sales and Value (2012-2017)
        3.1.1 Europe Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
    3.2 Europe Non-opioid Pain Patches Sales and Market Share by Type
    3.3 Europe Non-opioid Pain Patches Sales and Market Share by Application
    3.4 Europe Non-opioid Pain Patches Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Non-opioid Pain Patches Sales Volume by Countries (2012-2017)
        3.4.2 Europe Non-opioid Pain Patches Revenue by Countries (2012-2017)
        3.4.3 Germany Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        3.4.4 France Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        3.4.5 UK Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        3.4.6 Russia Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        3.4.7 Italy Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Non-opioid Pain Patches Sales and Growth Rate (2012-2017)

4 Middle East Non-opioid Pain Patches (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Non-opioid Pain Patches Sales and Value (2012-2017)
        4.1.1 Middle East Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
    4.2 Middle East Non-opioid Pain Patches Sales and Market Share by Type
    4.3 Middle East Non-opioid Pain Patches Sales and Market Share by Application
    4.4 Middle East Non-opioid Pain Patches Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Non-opioid Pain Patches Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Non-opioid Pain Patches Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        4.4.4 Israel Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        4.4.5 UAE Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        4.4.6 Iran Non-opioid Pain Patches Sales and Growth Rate (2012-2017)

5 Africa Non-opioid Pain Patches (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Non-opioid Pain Patches Sales and Value (2012-2017)
        5.1.1 Africa Non-opioid Pain Patches Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Non-opioid Pain Patches Revenue and Growth Rate (2012-2017)
    5.2 Africa Non-opioid Pain Patches Sales and Market Share by Type
    5.3 Africa Non-opioid Pain Patches Sales and Market Share by Application
    5.4 Africa Non-opioid Pain Patches Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Non-opioid Pain Patches Sales Volume by Countries (2012-2017)
        5.4.2 Africa Non-opioid Pain Patches Revenue by Countries (2012-2017)
        5.4.3 South Africa Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Non-opioid Pain Patches Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Non-opioid Pain Patches Sales and Growth Rate (2012-2017)

6 EMEA Non-opioid Pain Patches Manufacturers/Players Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GlaxoSmithKline
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Novartis AG
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Mylan N.V.
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Teva Pharmaceutical Industries
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Hisamitsu Pharmaceutical
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 TEH SENG Pharmaceutical
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Teikoku Seiyaku
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 IBSA Institut Biochimque SA
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Non-opioid Pain Patches Product Type, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Acorda Therapeutics
    6.12 Allergan PLC
    6.13 Endo International

7 Non-opioid Pain Patches Manufacturing Cost Analysis
    7.1 Non-opioid Pain Patches Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Non-opioid Pain Patches

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Non-opioid Pain Patches Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Non-opioid Pain Patches Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Non-opioid Pain Patches Market Forecast (2017-2022)
    11.1 EMEA Non-opioid Pain Patches Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Non-opioid Pain Patches Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Non-opioid Pain Patches Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Non-opioid Pain Patches Price and Trend Forecast (2017-2022)
    11.2 EMEA Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Non-opioid Pain Patches Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Non-opioid Pain Patches Sales Forecast by Type (2017-2022)
    11.7 EMEA Non-opioid Pain Patches Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer